Blood thinners at the end of life
This study looks at how blood-thinning medicines are used in people receiving palliative care near the end of life. It aims to find the best way to manage these medicines to improve comfort and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years of age or older.
- You must be receiving palliative care, either at home or in a residential facility.
- You must be able to give informed consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks doctors who care for patients in palliative care about how they make complex decisions regarding blood-thinning medications. Your answers could help improve guidance for these difficult choices.
This study looks at how well blood thinners (anticoagulants) work in people with cancer who have had a blood clot. It aims to compare the benefits and risks of different anticoagulant medicines.
This study builds a registry by asking adults who take blood thinners (anticoagulants) about their experiences. It may help improve care by learning how these medicines are used in real life.
This trial studies whether using blood-thinning medicine is safe and appropriate for people after an ischemic stroke who also have small signs of bleeding in the brain. It aims to balance stroke prevention with the risk of bigger bleeding.
This study looks at how people doing well on certain blood thinners do when they have a stroke or bleeding while taking them. It will measure medication levels in your blood to understand stroke severity and recovery in the short and long term.
This study tests personalized blood thinner treatments for people with blood clots in their lungs. It looks for patients who are older, have kidney problems, or have cancer, to see if adjusting the treatment helps them more.
Hear when a new Palliative Care trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.